During the past decade, North Bay Eye Associates conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Bay Eye Associates" #1 sponsor was "Aerie Pharmaceuticals" with 3 trials, followed by "Allergan" with 2 trials sponsored, "RVL Pharmaceuticals, Inc." with 2 trials sponsored, "SOLX, Inc." with 2 trials sponsored and "Aerpio Therapeutics" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

According to Clinical.Site data, the most researched conditions in "North Bay Eye Associates" are "Glaucoma" (4 trials), "Ocular Hypertension" (3 trials), "Blepharoptosis" (2 trials), "Dry Eye Syndromes" (2 trials) and "Glaucoma, Open Angle" (2 trials). Many other conditions were trialed in "North Bay Eye Associates" in a lesser frequency.

Most popular intervention types in "North Bay Eye Associates" are "Drug" (17 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Latanoprost ophthalmic solution" (2 trials), "RVL-1201" (2 trials), "Vehicle" (2 trials) and "Vehicle ophthalmic solution" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Bay Eye Associates" are 21 trials for "All" genders.

Currently, there are NaN active trials in "North Bay Eye Associates". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in North Bay Eye Associates, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Bay Eye Associates, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".